| 1. |
Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61(2):69-90.
|
| 2. |
Zhang ZM, Lai EC, Zhang C, et al. The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. Int J Surg, 2015, 20:8-16.
|
| 3. |
Pawarode A, Voravud N, Sriuranpong V, et al. Natural history of untreated primary hepatocellular carcinoma:a retrospective study of 157 patients. Am J Clin Oncol, 1998, 21(4):386-391.
|
| 4. |
Bruix J, Raoul JL, Sherman M, et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma:subanalyses of a phase III trial. J Hepatol, 2012, 57(4):821-829.
|
| 5. |
Shuqun C, Mengchao W, Han C, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology, 2007, 54(74):499-502.
|
| 6. |
Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg, 1989, 19(1):98-129.
|
| 7. |
Shi J, Lai EC, Li N, et al. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. Ann Surg Oncol, 2010, 17(8):2073-2080.
|
| 8. |
Xue TC, Xie XY, Zhang L, et al. Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus:a meta-analysis. BMC Gastroenterol, 2013, 13:60.
|
| 9. |
Chok KS, Cheung TT, Chan SC, et al. Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis. World J Surg, 2014, 38(2):490-496.
|
| 10. |
Kondo K, Chijiiwa K, Kai M, et al. Surgical strategy for hepatocellular carcinoma patients with portal vein tumor thrombus based on prognostic factors. J Gastrointest Surg, 2009, 13(6):1078-1083.
|
| 11. |
Peng BG, He Q, Li JP, et al. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg, 2009, 198(3):313-318.
|
| 12. |
Li Q, Wang J, Sun Y, et al. Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis-a randomized study. World J Surg, 2006, 30(11):2004-2011, discussion 2012-2013.
|
| 13. |
Yin J, Li N, Han Y, et al. Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virusrelated hepatocellular carcinoma:a two-stage longitudinal clinical study. J Clin Oncol, 2013, 31(29):3647-3655.
|
| 14. |
Kamiyama T, Nakanishi K, Yokoo H, et al. Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol, 2007, 12(5):363-368.
|
| 15. |
Tang QH, Li AJ, Yang GM, et al. Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus:a comparative study. World J Surg, 2013, 37(6):1362-1370.
|
| 16. |
Liu L, Zhang C, Zhao Y, et al. Transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis:prognostic factors in a single-center study of 188 patients. Biomed Res Int, 2014, 2014:194278.
|
| 17. |
Chung GE, Lee JH, Kim HY, et al. Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival. Radiology, 2011, 258(2):627-634.
|
| 18. |
Chern MC, Chuang VP, Liang CT, et al. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion:safety, efficacy, and prognostic factors. J Vasc Interv Radiol, 2014, 25(1):32-40.
|
| 19. |
Niu ZJ, Ma YL, Kang P, et al. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus:using a new classification. Med Oncol, 2012, 29(4):2992-2997.
|
| 20. |
Nakazawa T, Adachi S, Kitano M, et al. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels. Oncology, 2007, 73(1-2):90-97.
|
| 21. |
Sugahara S, Nakayama H, Fukuda K, et al. Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis. Strahlenther Onkol, 2009, 185(12):782-788.
|
| 22. |
Yoon SM, Lim YS, Won HJ, et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein:long-term patient outcomes. Int J Radiat Oncol Biol Phys, 2012, 82(5):2004-2011.
|
| 23. |
Choi Y, Kim JW, Cha H, et al. Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy. J Radiat Res, 2014, 55(1):113-120.
|
| 24. |
羅劍鈞, 顏志平, 王建華, 等. 腔內植入125I粒子條及支架聯合經動脈化療栓塞治療原發性肝癌合并門脈主干癌栓的療效. 中華腫瘤雜志, 2011, 33(7):535-539.
|
| 25. |
Lau WY, Sangro B, Chen PJ, et al. Treatment for hepatocellular car\cinoma with portal vein tumor thrombosis:the emerging role for radioembolization using yttrium-90. Oncology, 2013, 84(5):311-318.
|
| 26. |
Gramenzi A, Golfieri R, Mosconi C, et al. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma:a cohort study with propensity score analysis. Liver Int, 2015, 35(3):1036-1047.
|
| 27. |
Forner A, Reig ME, de Lope CR, et al. Current strategy for staging and treatment:the BCLC update and future prospects. Semin Liver Dis, 2010, 30(1):61-74.
|
| 28. |
Zhu K, Chen J, Lai L, et al. Hepatocellular carcinoma with portal vein tumor thrombus:treatment with transarterial chemoembolization combined with sorafenib-a retrospective controlled study. Radiology, 2014, 272(1):284-293.
|
| 29. |
Ueda H, Fukuchi H, Tanaka C. Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review). Oncol Lett, 2012, 3(2):259-263.
|
| 30. |
Qin S, Bai Y, Lim HY, et al. Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. J Clin Oncol, 2013, 31(28):3501-3508.
|
| 31. |
中華人民共和國衛生部. 原發性肝癌診療規范(2011年版). 臨床肝膽病雜志, 2011, 27(11):1141-1159.
|
| 32. |
Zhang Y, Guan DX, Shi J, et al. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer. J Hepatol, 2013, 59(6):1255-1263.
|
| 33. |
Giorgio A, de Stefano G, Di Sarno A, et al. Radiofrequency ablation of hepatocellular carcinoma extended into the portal vein:Preliminary results. J Ultrasound, 2009, 12(1):32-37.
|
| 34. |
Zheng JS, Long J, Sun B, et al. Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis:extending the indication for ablation? Clin Radiol, 2014, 69(6):e253-e263.
|
| 35. |
Lu ZH, Shen F, Yan ZL, et al. Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation. J Cancer Res Clin Oncol, 2009, 135(6):783-789.
|
| 36. |
Vibert E, Azoulay D, Cunha AS, et al. Portal stenting for hepatocellular carcinoma extending into the portal vein in cirrhotic patients. J Surg Oncol, 2013, 107(7):696-701.
|
| 37. |
Zhang XB, Wang JH, Yan ZP, et al. Hepatocellular carcinoma with main portal vein tumor thrombus:treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization. Cancer, 2009, 115(6):1245-1252.
|
1/5
WeChat